Affordable Access

deepdyve-link
Publisher Website

Antenatal exposure to sulindac and risk of necrotizing enterocolitis.

Authors
  • Kamath-Rayne, Beena D1
  • Habli, Mounira2
  • Rodriguez, Zahidee3
  • Wu, Malcolm4
  • Gresh, James4
  • DeFranco, Emily A5
  • 1 Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Electronic address: [email protected]
  • 2 Fetal Care Center of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, OH.
  • 3 Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • 4 University of Cincinnati, Cincinnati, OH.
  • 5 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati School of Medicine, Cincinnati, OH.
Type
Published Article
Journal
American journal of obstetrics and gynecology
Publication Date
January 2015
Volume
212
Issue
1
Identifiers
DOI: 10.1016/j.ajog.2014.07.051
PMID: 25088864
Source
Medline
Keywords
License
Unknown

Abstract

Our data demonstrate an adverse association of sulindac with NEC. These findings deserve further investigation and using sulindac as a tocolytic agent requires caution.

Report this publication

Statistics

Seen <100 times